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OBJECTIVES: The development of sepsis after abdominal surgery is associated with high morbidity and
mortality. Due to inflammation, it may be difficult to diagnose infection when it occurs, but measurement of
C-reactive protein could facilitate this diagnosis. In the present study, we evaluated the predictive value and
time course of C-reactive protein in relation to outcome in patients admitted to the intensive care unit (ICU)
after abdominal surgery.
METHODS: We included patients admitted to the ICU after abdominal surgery over a period of two years. The
patients were divided into two groups according to their outcome: favorable (F; left the ICU alive, without
modification of the antibiotic regimen) and unfavorable (D; death in the ICU, surgical revision with or without
modification of the antibiotic regimen or just modification of the regimen). We then compared the highest
C-reactive protein level on the first day of admission between the two groups.
RESULTS: A total of 308 patients were included: 86 patients had an unfavorable outcome (group D) and 222 had
a favorable outcome (group F). The groups were similar in terms of leukocytosis, neutrophilia, and platelet
count. C-reactive protein was significantly higher at admission in group D and was the best predictor of an
unfavorable outcome, with a sensitivity of 74% and a specificity of 72% for a threshold of 41 mg/L. No changes
in C-reactive protein, as assessed based on the delta C-reactive protein, especially at days 4 and 5, were
associated with a poor prognosis.
CONCLUSIONS: A C-reactive protein cut-off of 41 mg/L during the first day of ICU admission after abdominal
surgery was a predictor of an adverse outcome. However, no changes in the C-reactive protein concentration,
especially by day 4 or 5, could identify patients at risk of death.
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’ INTRODUCTION
Sepsis, defined as a clinically suspected or proven infection
associated with an inadequate systemic immune response, is
characterized by hemodynamic, metabolic, and both pro-
and anti-inflammatory derangements. In less severe cases,
these derangements are defined as non-specific signs (also
called systemic inflammatory response syndrome, or SIRS).
More severe cases, with dysfunction of at least one organ, are
called severe sepsis or are termed septic shock if there is
associated hypotension requiring vasopressor therapy to
maintain the mean blood pressure at 65 mmHg or greater
and if the serum lactate level is greater than 2 mmol/L (1,2).
Although the intensive care unit (ICU) mortality rates for
patients with severe sepsis or septic shock have decreased
from 50% to 25-30% in recent years (3), these rates remain
high, and there is also considerable morbidity related to the
associated organ dysfunction (4). The decreased mortality
over the years has perhaps been due to better awareness and
recognition of the syndrome, resulting in more rapid institu-
tion of aggressive management, including fluid resuscitation,
monitoring and appropriate empirical antibiotic therapy
(3,5,6) as well as both identification of infectious foci and
surgical intervention, if required.
Considerable effort is being placed on identifying biomar-
kers that can be used to detect sepsis in an early and
reversible phase to decrease mortality from this disease (7).
In the management of septic patients, it is also imperative to
closely monitor the progression of the disease and to
evaluate the likely prognosis because this information may
influence individual clinical interventions (1). Therefore,
there is a need for biomarkers that can help in the monitoring
and staging of sepsis and, consequently, in guiding ther-
apeutic management (7-9). Ideally, biomarker measurement
should be easy, fast and inexpensive, and the results should
have high specificity and sensitivity for sepsis. Several
biomarkers have been proposed or are under investigation
in the context of sepsis (7,10-13). In particular, C-reactiveDOI: 10.6061/clinics/2017(01)05
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protein (CRP) measurements are already widely used for this
purpose in critically ill patients (14).
Despite its routine clinical use, few studies have examined
the CRP concentration as a biomarker of infection in critically
ill patients, and the results have not been consistent. In a recent
review of studies performed in critically ill patients, Lelubre
et al. (14) suggested that the time course of CRP is more useful
than a single measurement. However, the numbers of patients
included in the studies were limited, the causes of sepsis were
very heterogeneous, and few surgical ICU patients were
included (14). In a meta-analysis, Zhang and Ni confirmed this
study heterogeneity (I2=92%), limiting understanding of the
contribution of CRP to prognosis (15).
The development of sepsis in critically ill patients after
abdominal surgery, even if scheduled surgery, is associated
with high morbidity and mortality (16). Due to persistent
inflammation, it may be difficult to diagnose infection when
it occurs (17). Despite its potential role as a biomarker of
infection, few studies have assessed the usefulness of CRP in
the diagnosis of sepsis after abdominal surgery in critically ill
patients (18,19). For these reasons, we investigated the
predictive value of the CRP concentrations on the first day
of ICU admission compared to other inflammatory para-
meters and the time course of CRP in relation to ICU
outcome, defined as favorable (discharged alive from the
ICU, without modification of antibiotherapy) or unfavorable
(modification of antibiotherapy during the ICU stay, a new
abdominal surgical intervention for uncontrolled sepsis with
or without modification of the initial antibiotic regimen, or
ICU death), in critically ill patients admitted to the ICU after
abdominal surgery.
’ METHODS
This study was conducted in the 36-bed medicosurgical
ICU of CHU-Charleroi, Belgium. We retrieved data for all
adult (X18 years) patients admitted to the ICU after major
abdominal surgery between January 1, 2011, and December
31, 2012. Patients without complete biological or clinical data
were excluded. The local ethical committee approved the
study but waived the need for informed consent because of
the retrospective nature of the study.
Demographic data at admission were recorded, including
age, sex, height, weight, type of abdominal surgery, timing of
surgery (scheduled or emergency), APACHE II (20) and
SOFA (21) scores, length of ICU stay and ICU mortality. On
the first day of the ICU stay, the following treatment and
clinical data were collected: maximum dose of vasopressors,
highest temperature, lowest mean blood pressure, lowest
PaO2/FiO2, and diuresis. For each day during the ICU stay,
we retrieved the platelet, white blood cell and neutrophil
counts and the hemoglobin, fibrinogen, urea, creatinine,
bilirubin, lactate and serum CRP concentrations. We calcu-
lated the delta CRP concentration as the highest value of
CRP on a particular day minus the CRP concentration on the
day of admission. Any antibiotherapy administered during
the ICU stay was noted.
Hemodynamic management of these septic patients was in
agreement with the Surviving Sepsis Campaign recommen-
dations (1). All patients received prophylactic or empirical
antibiotic therapy before surgery, in agreement with local
policy. No protocol concerning ICU admission after major
abdominal surgery was in place at our institution; never-
theless, we arbitrarily defined a patient with major abdominal
surgery as a patient with hemodynamic instability during the
surgery; with a transfusion requirement; or with significant
comorbidities, such as impairment of the left ventricular
ejection fraction, chronic obstructive pulmonary disease, or
chronic renal failure. All signs of tissue hypoperfusion before
or during surgery motivated admission to the ICU.
We defined a patient with a favorable ICU outcome as a
patient who was discharged alive from the ICU, without
modification of antibiotherapy. In contrast, an unfavorable
outcome was defined as requiring a modification of antibio-
therapy during the ICU stay, a new abdominal surgical inter-
vention for uncontrolled sepsis with or without modification
of the initial antibiotic regimen, or ICU death.
Statistical analysis
Statistical analyses were performed using XLSTAT2013
(ADDINSOFTs). The data are presented as the median+/-
IQR or the count (percentage), unless stated otherwise. All
tests were two sided, and a p-valueo0.05 was considered
statistically significant. Comparisons between groups were
performed using a Mann-Whitney test for continuous var-
iables or Fisher’s exact test for dichotomous variables.
ROC curves were computed to compare the ability of
inflammatory markers to predict an unfavorable outcome.
Evolution of the CRP concentration over time and between
groups was analyzed by ANOVA for repeated measures.
Additionally, pairwise comparisons were performed using a
Tukey test.
’ RESULTS
During the 2-year study period, 4482 patients were
admitted to our ICU. Of these, 333 patients (13.5%) were
admitted after major abdominal surgery. After exclusion of
25 patients because of a lack of data (particularly no measure-
ments of CRP concentrations), the final analysis included 308
patients (Figure 1).
The patient's characteristics are summarized in Table 1.
Their median age was 63 [52-72] years, and 50.6% were male.
The median APACHE II score was 11 [6-16], and the median
Figure 1 - Flow chart of the patient selection.
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SOFA score was 3 [1-4]. In total, 14% of patients were treated
with vasopressors on the first ICU day. The majority of the
abdominal surgeries were colorectal (47%), and 132 (43%)
surgeries were not planned. The median ICU length of stay
was 3 [2-5] days, and ICU mortality was 8%. CRP
concentrations were low on the first day of ICU admission
for all patients included, with a median of 28 [7-163] mg/L.
We compared, on ICU admission, patients admitted for
scheduled or emergency surgery. The patient's characteristics
are summarized in Table 2. As expected, ICU severity scores,
ICU and hospital lengths of stay and mortality were higher
among those with emergency surgery. Among the inflam-
matory markers examined, CRP concentrations were also
higher in these patients, whereas the white blood cell count
was not higher and neutrophilia was not more frequent
(Table 2). A weak but significant correlation was observed
between SOFA scores and CRP concentrations at ICU
admission for all patients (r=0.27; po0.0001).
Of the 308 patients, 222 (72%) had a favorable outcome
(Figure 1). Among the remaining 86 patients with an
unfavorable outcome, 25 (8% of the total population, 29%
of the patients with an unfavorable outcome) died during
their ICU stay. Mortality was significantly higher in those
with emergency surgery than in those with scheduled
surgery (18 vs 7 deaths, p=0.001). Empirical antibiotherapy
was altered during the ICU stay for 37 patients (12% of the
total population, 33% of the patients with an unfavorable
outcome), and 24 patients (8% of the total population, 28%
of the patients with an unfavorable outcome) needed a
new abdominal surgical intervention with or without
modification of their antibiotic regimen during their ICU
stay (Figure 1).
Comparisons of clinical characteristics and biological data
between patients with favorable and unfavorable outcomes
are shown in Table 3. As expected, ICU severity scores and
the ICU length of stay were higher in patients with an
unfavorable outcome. In total, 28 patients in this subgroup
(32.6%) were in septic shock (median dose of norepinephrine:
0.39 [0.17-0.58] vs 0.20 [0.12-0.29] mcg/kg/h for patients
with a favorable outcome, p=0.024) and were more likely to
have pulmonary (lower P/F: 220 [143-314] vs 315 [234-426],
po0.001) or renal (higher creatinine concentrations: 1.06
[0.80-2.00] vs 0.90 [0.70-1.12] mg/dL, p=0.002; higher urea
concentrations: 51 [31-82] vs 32 [23-45] mg/dL, po0.001)
organ dysfunction and lower urinary output (850 [558-1290]
vs 1100 [710-1670] mL, p=0.002) on the first ICU day. Lactate
concentrations were also more elevated in the patients with
an unfavorable outcome (Table 3).
Among the inflammatory biomarkers examined, only CRP
values were significantly different between the groups: 13.6
[5-86] mg/L for those with a favorable outcome vs 140.5
[45.0-314.6] mg/L for those with an unfavorable outcome,
po0.001; Table 2).
We observed a weak correlation between ICU SOFA scores
and CRP concentrations only in the group with an unfavor-
able outcome (r=0.28; p=0.01).
CRP was the inflammatory marker that best predicted a
poor outcome, with an area under the ROC curve of 0.78
[0.71-0.84] (po0.0001; Figure 2). A CRP concentration
threshold of 41 mg/L permitted prediction of ICU outcome
with a sensitivity of 74% (62-83), a specificity of 72% (65-79),
a positive likelihood ratio of 2.7, and a negative likelihood
ratio of 0.37. After the CRP concentration, the lactate
concentration had the highest area under the ROC curve
(0.73 [0.66-0.80], po0.0001; with a sensitivity of 82% and a
specificity of 55% for a threshold of 15.6 mg/dL). In contrast,
leukocytosis (AUC: 0.43 [0.32-0.53], p=0.18), neutrophilia
(AUC: 0.43 [0.3-0.53], p=0.34) and temperature (AUC: 0.53
[0.44-0.64], p=0.49) did not have significant predictive value
(Figure 2).
For the 86 patients with an unfavorable outcome, we
analyzed the delta CRP concentrations in the three sub-
groups (modification of the empirical antibiotic regimen,
new surgery with or without modification of the antibiotic
regimen and death) (Figure 3). There was a significant
difference in the delta CRP for day 4/day 0 (p=0.025) and
day 5/day 0 (p=0.05) between patients who only had
modification of their antibiotic regiment and patients who
died (Figure 3).
’ DISCUSSION
Sepsis complicating major abdominal surgery is associated
with high morbidity and mortality (16,30). Use of a
biomarker, such as CRP, in addition to clinical signs may
help clinicians to diagnose sepsis early and to start timely
treatment.
In this study, we showed that CRP concentrations during
the first ICU day were a good marker of outcome. In
particular, a value greater than 41 mg/L had high specificity
for an unfavorable outcome. Moreover, the time course of the
CRP concentration, as assessed based on the delta CRP,
differentiated between patients who died and those who
only needed a change in their antibiotic treatment.
Table 1 - Demographic, clinical and biological character-
istics of all patients admitted to the ICU after abdominal surgery
(n=308).
Age (years) 63 [52-72]
Sex (M/F) 50.6 /49.4
Apache II score 11 [6-16]
SOFA score 3 [1-4]
Temperature (oC) 36.0 [35.1-37.1]
Mean arterial blood pressure (mmHg) 69 [61-82]
Height (cm) 168 [160-175]
Weight (kg) 73 [61-95]
NorE dosage (mcg/kg h-) (% of patients) 0.26 [0.15-0.48] (14%)
Diuresis on first day (mL) 1010 [650-1600]
PaO2/FiO2 290 [205-378]
Hb (g/dL) 10.9 [9.3-12.7]
WBCs (103/mm3) 9745 [6010-14600]
Neutrophils (103/mm3) 9.14 [5.43-14.26]
Platelets (103/mm3) 216 [159-282]
Fibrinogen (g/L) 3.72 [2.62-5.26]
Urea (mg/dL) 35 [25-52]
Creatinine (mg/dL) 0. 99 [0.72-1.30]
Bilirubin (mg/dL) 0.7 [0.5-1.2]
CRP (mg/L) 28 [7-163]
Lactate (mEq/L) 19 [12-31]
ICU length of stay (days) 3 [2-5]
Hospital length of stay (days) 16 [10-32]
Type of surgery, n (%) Colorectal: 146 (47)
Bariatric: 42 (14)
Hepatobiliary-pancreas: 45 (15)
Esophageal-stomach: 32 (10)
Urology: 31 (10)
Gynecology: 12 (4)
ICU death, n (%) 25 (8)
NorE: norepinephrine; Hb: hemoglobin; WBCs: white blood cells (normal
range: 4.00-10.00 x 103/mm3). Neutrophilia: normal range: 40.0-80.00%.
Results shown as median [interquartile range] unless stated otherwise.
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These findings have already been reported for ICU
patients, and notably patients with community- or ventila-
tor-acquired pneumonia (23,24), bacteremia (25,26) or hepa-
tic failure (27,28). In contrast, in the present study, the CRP
values were analyzed and related to outcome in a large
cohort of ICU patients after abdominal surgery. Indeed, CRP
has often been studied as a potential marker for diagnosis
and/or the need to reoperate (19,29-32). For diagnosis of
infection in ICU patients, however, the results of the various
studies have been contradictory (14,18,19), but an increase in
CRP levels has been described as a crucial indicator for the
diagnosis of postoperative complications, such as infection,
Table 2 - Comparisons of demographic, clinical and biological characteristics between patients with scheduled surgery (n=176) and
patients with emergency surgery (n=132).
Scheduled surgery Emergency surgery p-value
Age (years) 62[52-69] 63[51-78] 0.22
Sex (M/F) 93/83 62/70 0.37
Apache II score 9[6-13] 14[10-20] o0.0001
SOFA score 2[1-3] 4[1-6] o0.0001
Temperature (oC) 35.8[35.1-35.9] 36.0[35.2-37.4] 0.01
Mean arterial blood pressure (mmHg) 73[62-82] 66[60-79] 0.04
Height (cm) 166[160-173] 168[160-175] 0.66
Weight (kg) 75[67-103] 70[60-85] 0.0003
NorE dosage (mcg/kg h) (% of patients) 0.14[0.09-0.20] (6) 0.34[0.18-0.55] (25) 0.01
Diuresis on first day (mL) 1155[798-1766] 820[550-1265] o0.0001
PaO2/FiO2 307[230-403] 267[165-355] 0.002
Hb (g/dL) 11.0[9.5-12.6] 10.5[9.0-12.7] 0.20
WBCs (103/mm3) 11.8[8.1-22.6] 11.7[4.5-17.3] 0.87
Neutrophils (103/mm3) 9.7[6.4-13.7] 8.9[4.7-14.6] 0.81
Platelets (103/mm3) 217[160-268] 216[159-310] 0.6
Fibrinogen (g/L) 3.2[2.5-4.2] 4.5[3.2-7.5] o0.0001
Urea (mg/dL) 34[26-38] 37[33-42] o0.0001
Creatinine (mg/dL) 0.88[0.70-1.10] 1.08[0.80-1.82] o0.0001
Bilirubin (mg/dL) 0.62[0.44-1.00] 0.80[0.60-1.30] 0.02
CRP (mg/L) 8[4-21] 171[64-322] o0.0001
Lactate (mEq/L) 13.5[9.0-21.8] 14.5[8.0-23.4] 0.86
ICU length of stay (days) 2[2-4] 4[3-7] o0.0001
Hospital length of stay (days) 14[8-25] 24[13-48] o0.0001
ICU death 7 18 0.001
NorE: norepinephrine; Hb: hemoglobin; WBCs: white blood cells (normal range: 4.00-10.00 x 103/mm3). Neutrophilia: normal range: 40.0-80.00%. Results
shown as median [interquartile range] unless stated otherwise.
Table 3 - Comparisons of demographic, clinical and biological characteristics between patients with favorable (n=222) and
unfavorable (n=86) ICU outcomes.
Favorable Unfavorable p-value
Age (years) 63[56-72] 63[50-72] 0.19
Sex (M/F) 108/114 46/40 0.45
Apache II score 9[6-14] 16[12-22] o0.001
SOFA score 2[1-4] 4[3-8] o0.001
Temperature (oC) 35.8[35.1-37.0] 36.4[35.1-37.4] 0.017
Mean arterial blood pressure (mmHg) 73[62-83] 64[59-76] 0.001
Height (cm) 166[160-174] 170[160-175] 0.4
Weight (kg) 73.5[63.5-99.5] 70.0[60.0-87.0] 0.1
NorE dosage (mcg/kg h) (% of patients) 0.2[0.12-0.23] (32.6) 0.39[0.17-0.59] (6.7) 0.024
Diuresis on first day (mL) 1100[710-1670] 850[558-1290] 0.002
PaO2/FiO2 315[234-426] 220[143-313] o0.001
Hb (g/dL) 11.0[9.5-12.8] 10.7[8.8-12.1] 0.08
WBCs (103/mm3) 11.89[8.60-15.98] 10.32[4.34-17.00] 0.12
Neutrophils (103/mm3) 9.53[6.20-14.03] 8.02[2.47-14.66] 0.20
Platelets (103/mm3) 216[163-276] 215[142-282] 0.62
Fibrinogen (g/L) 3.65[2.55-5.20] 4.26[2.67-6.16] 0.24
Urea (mg/dL) 32[23-45] 51[31-82] o0.001
Creatinine (mg/dL) 0.90[0.70-1.12] 1.06[0.80-2.00] 0.002
Bilirubin (mg/dL) 0.70[0.50-1.12] 0.80[0.49-1.39] 0.36
CRP (mg/L) 14[5-86] 141[45-315] o0.001
Lactate (mEq/L) 15.0[10.0-24.5] 26.0[18.0-42.8] o0.001
ICU length of stay (days) 2[2-4] 7[4-15] o0.001
Hospital length of stay (days) 15[9-25] 35[14-53] o0.001
ICU death 0 25 o0.001
NorE: norepinephrine; Hb: hemoglobin; WBCs: white blood cells (normal range: 4.00-10.00 x 103/mm3). Neutrophilia: normal range: 40.0-80.00%. Results
shown as median [interquartile range] unless stated otherwise.
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sepsis, anastomotic leakage or mesenteric ischemia (19,
29-31). For example, CRP levels 4140 mg/L on the 4th
postoperative day after rectal surgery with primary anasto-
mosis had a 91% predictive value for a complicated
postoperative course (30). In contrast, in a recent systematic
review and meta-analysis, Singh et al. reported that seven
studies with a total of 2483 patients indicated the ‘‘useful-
ness’’ of CRP values as a negative predictive marker for the
development of anastomotic leakage following colorectal
surgery (32).
Figure 2 - ROC curves for the measured inflammatory parameters at ICU admission for all patients. The area under the curve (AUC)
values were as follows: CRP: 0.78 [0.71-0.84], po0.0001; lactate concentration (LACT): 0.73 [0.66-0.80], po0.0001; leukocytosis (WBCs):
(0.43 [0.32-0.53], p=0.18); neutrophilia (N): 0.43 [0.3-0.53], p=0.34; and temperature (To): 0.53 [0.44-0.64], p=0.49.
Figure 3 - Changes in delta CRP in the patients with an unfavorable outcome (death, surgical re-intervention, or a change in antibiotic
regimen; n=86). The evolution of the CRP concentration over time and between groups was analyzed using ANOVA for repeated
measures.
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Regarding ICU patients after abdominal surgery, the
number of studies is limited. Indeed, Schmit and Vincent
(18) reported the time course of CRP concentrations in 50
septic patients with adequate (n=24) or inadequate (n=18)
empiric antibiotherapy and in surgical patients who needed
reoperation for uncontrolled infection (n=8). As expected,
CRP concentrations decreased faster during the first 48 hours
when the antibiotherapy was adequate, and an increase in
the CRP concentration by a minimum of 22 mg/L over the
48-hour period was predictive of inadequate antibiotherapy,
with a sensitivity of 77% and a specificity of 67% (18). The
results were identical if a longer delay was allowed between
CRP measurements. The take-home message of that study is
the need for at least two CRP measurements separated by a
delay of 48 hours to estimate the appropriateness of anti-
biotherapy, as also suggested by the meta-analysis by Zhang
and Ni (15). Another interesting aspect of the aforemen-
tioned study (18) was the time course of CRP in a surgical
population with uncontrolled infection. Regrettably, how-
ever, the number of patients studied was limited (n=8), and
the delay to reoperation in cases with uncontrolled infection
was not reported, limiting the conclusions that can be drawn
regarding the usefulness of CRP values in this particular
population (30).
In a prospective, monocentric observational study that
included 174 surgical patients, Meyer et al. (19) reported that
a 10% increase in the CRP concentration resulted in a 3.5%
increase in the odds of an event (a diagnostic or therapeutic
intervention; OR 1.035, 95% CI: 1.004-1.068, p=0.028). Never-
theless, an increase in the CRP level did not lead to higher
odds of complications (OR 0.983, 95% CI: 0.932-1.036,
p=0.52), even after adjustment for the SOFA score (OR
0.980, 95% CI: 0.929-1.035, p=0.46). Hence, the authors
concluded that an increase in the CRP concentration was a
poor marker of complications in surgical patients. There are
several differences between our study and the study by
Meyer et al. (19). For example, we included only patients
admitted post-operatively after major abdominal surgery,
whereas Meyer et al. included all surgical patients (especially
vascular surgery patients) except those who had cardiac
surgery. Moreover, more than 10% of their patients were
admitted to the ICU for sepsis (19), and a large number of
these patients were admitted following re-exploration for
complications from earlier surgery (18%). Considering the
outcome of patients, defined as favorable or unfavorable
(death, change in antibiotic regimen or reoperation with or
without modification of antibiotherapy), Meyer et al. (19)
reported a large number of events (for example, a need for
gastroscopy or CT scan), but these were not necessarily
linked to very severe complications in the patients. Indeed,
the number of futile events in that study is unclear. This may
partly explain why the authors observed a relationship
between events and CRP concentrations, but not between
complications and CRP concentrations.
Our study also has certain limitations. First, we excluded
25 patients (2%) from the final analysis due to a lack of data;
this was necessary because of the retrospective nature of the
study. Although a prospective study design would have
prevented this issue, the percentage of patients excluded was
still low. Similarly, the absence of a fixed rule for ICU
admission of these patients may have biased the results.
Nevertheless, the relatively long study period of 2 years
should have limited the potential effects of periods of lower
or higher ICU admission rates. Second, the group of patients
with an unfavorable outcome was heterogeneous (with
outcomes including death, a change in antibiotic regimen
and new surgery), although we analyzed these subgroups
separately to determine the delta concentrations (Figure 3).
However, larger, separate groups will be needed to confirm
our results. Third, the CRP concentrations may have been
underestimated because of hemodilution due to fluid
infusion during surgery or during the ICU stay and also
vascular leakage, as observed in critically ill patients, and
especially septic patients. This last point could be assessed
based on the ratio of albumin or protein concentration to the
CRP concentration (33). Regrettably, though, we do not have
data on albumin concentrations for our patients because this
parameter is not measured routinely in our ICU patients.
Fourth, we measured the concentrations of CRP and certain
other inflammatory markers but did not measure other
markers, such as CD64 and triggering receptor expressed on
myeloid cells (TREM). These other biomarkers may have
greater sensitivity for outcome in this particular population
(34) but are not routinely measured and need to be further
validated. We preferred to study CRP concentrations because
they are easy, rapid, and inexpensive to determine and very
reproducible.
Fifth, given the design of the study (retrospective and not
blind to the CRP values), we cannot exclude the possibility
that the judgment of the clinicians was influenced by the
CRP values, including their decision to change the antibiotic
regimen or to perform new surgery or drainage. Sixth, due to
the retrospective design of our study, we used the definition
of SIRS, rather than the new definition of sepsis (2) or the
‘‘quick’’ SOFA score (including hypotension, altered menta-
tion, and tachypnea). Other studies with comparisons
between CRP concentrations and the ‘‘quick’’ SOFA criteria
are needed to prompt clinicians to further evaluate patients
for the presence of infection and/or organ dysfunction.
In conclusion, a CRP threshold of 41 mg/L during the first
day of ICU admission after major abdominal surgery is a
good predictor of an unfavorable outcome. However, no
changes in the CRP concentration over time (delta CRP),
especially at day 4 or 5, can help to identify patients at risk of
death.
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